{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:35:27Z","timestamp":1794558927067,"version":"4.9.1"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"Importance<\/jats:title>Inadequate representation of older patients, women, and racial minority individuals in cardiovascular clinical trials limits both the generalizability of trial findings and inclusivity in access to novel therapies and therapeutic strategies.<\/jats:p><\/jats:sec>Objective<\/jats:title>To report on temporal trends in the representation of older patients, women, and racial and ethnic minority individuals in clinical trials studying treatments for valvular heart disease.<\/jats:p><\/jats:sec>Evidence Review<\/jats:title>All published clinical trials enrolling more than 100 adults with any valvular heart disease published between 2005 and 2020 were included after searches with PubMed and ClinicalTrials.gov. Data on age, sex, race, and ethnicity reported in the included studies were collected. Trials were assigned to 4 time periods based on the publication date, and temporal trends were analyzed in the representation of older patients, women, and racial and ethnic minority individuals.<\/jats:p><\/jats:sec>Findings<\/jats:title>A total of 139 clinical trials with 51\u202f527 participants were identified. Of these trials, 103 (74%) investigated aortic valve disease and the remainder mitral valve disease. Overall, 63 trials (45.3%) enrolled patients only in Europe, 24 (17.3%) only in North America, and 19 (13.7%) in multiple geographical regions. The weighted mean (SD) age of enrolled patients was 68.4 (11.4) years, increasing nonsignificantly from 61.9 (5.9) years in 2005-2008 to 72.8 (9.6) years in 2017-2020 (P<\/jats:italic>\u2009=\u2009.09 for trend). The overall proportion of women enrolled in valvular heart disease trials was 41.1%, with no significant changes over time. Data on race and ethnicity of trial participants were reported in 13 trials (9.4%), in which trial-level representation of American Indian\/Alaska Native, Asian, Black\/African American, Hispanic, and Native Hawaiian\/Pacific Islander patients ranged from 0.27% to 43.9%. There were no significant temporal trends noted in the enrollment of racial and ethnic minority populations. The representation of women in clinical trials was positively associated with enrollment rates of older patients and underrepresented racial and ethnic groups.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This review found that over the past 2 decades, women and racial and ethnic minority individuals have remained underrepresented in North American valvular heart disease clinical trials. Further work is needed to improve the reporting of race and ethnicity data and address barriers to trial enrollment for older patients, women, and racial and ethnic minority individuals.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamacardio.2023.2098","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T18:00:20Z","timestamp":1690394420000},"page":"871","source":"Crossref","is-referenced-by-count":34,"title":["Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials"],"prefix":"10.1001","volume":"8","author":[{"given":"Kriyana P.","family":"Reddy","sequence":"first","affiliation":[{"name":"Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Faggioni","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Eberly","sequence":"additional","affiliation":[{"name":"Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, University of Pennsylvania, Philadelphia"},{"name":"Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Halaby","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Sanghavi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lewey","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"},{"name":"Associate Editor, JAMA Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Coylewright","sequence":"additional","affiliation":[{"name":"Erlanger Health System, Chattanooga, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard C.","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Giri","sequence":"additional","affiliation":[{"name":"Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, University of Pennsylvania, Philadelphia"},{"name":"Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Fanaroff","sequence":"additional","affiliation":[{"name":"Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, University of Pennsylvania, Philadelphia"},{"name":"Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin S.","family":"Nathan","sequence":"additional","affiliation":[{"name":"Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, University of Pennsylvania, Philadelphia"},{"name":"Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"hrv230001r1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015594","article-title":"Ten-year trends in enrollment of women and minorities in pivotal trials supporting recent US Food and Drug Administration approval of novel cardiometabolic drugs.","volume":"9","author":"Khan","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"hrv230001r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106740","article-title":"Inclusion and diversity in clinical trials: Actionable steps to drive lasting change.","volume":"116","author":"Kelsey","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"10","key":"hrv230001r4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1001\/jamacardio.2018.2559","article-title":"Enrollment of older patients, women, and racial and ethnic minorities in contemporary heart failure clinical trials: a systematic review.","volume":"3","author":"Tahhan","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"6","key":"hrv230001r5","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/jamacardio.2020.0359","article-title":"Enrollment of older patients, women, and racial\/ethnic minority groups in contemporary acute coronary syndrome clinical trials: a systematic review.","volume":"5","author":"Tahhan","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"10","key":"hrv230001r6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jcin.2019.03.007","article-title":"Racial disparities in the utilization and outcomes of TAVR: TVT registry report.","volume":"12","author":"Alkhouli","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"hrv230001r7","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"18","key":"hrv230001r9","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.jacc.2018.02.070","article-title":"Participation of women in clinical trials supporting FDA approval of cardiovascular drugs.","volume":"71","author":"Scott","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"hrv230001r10","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.jacc.2021.09.855","article-title":"Trends in transcatheter and surgical aortic valve replacement among older adults in the United States.","volume":"78","author":"Mori","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"hrv230001r11","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/j.jcin.2020.08.015","article-title":"The use of CTCA for planning PCI: using the 3D coronary tree information.","volume":"13","author":"Carroll","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"hrv230001r12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/2229-3485.167099","article-title":"Elderly patients\u2019 participation in clinical trials.","volume":"6","author":"Shenoy","year":"2015","journal-title":"Perspect Clin Res"},{"issue":"5","key":"hrv230001r13","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3390\/jcm9051571","article-title":"Strategies to improve participation of older adults in cancer research.","volume":"9","author":"Liu","year":"2020","journal-title":"J Clin Med"},{"issue":"7","key":"hrv230001r14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1056\/NEJM200008173430706","article-title":"Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute.","volume":"343","author":"Harris","year":"2000","journal-title":"N Engl J Med"},{"issue":"1","key":"hrv230001r15","doi-asserted-by":"publisher","first-page":"708","DOI":"10.18549\/PharmPract.2016.01.708","article-title":"Women\u2019s involvement in clinical trials: historical perspective and future implications.","volume":"14","author":"Liu","year":"2016","journal-title":"Pharm Pract (Granada)"},{"issue":"4","key":"hrv230001r16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCRESAHA.121.319914","article-title":"Sex differences and similarities in valvular heart disease.","volume":"130","author":"DesJardin","year":"2022","journal-title":"Circ Res"},{"key":"hrv230001r17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2022.100093","article-title":"Representation of women in heart failure clinical trials: Barriers to enrollment and strategies to close the gap.","volume":"13","author":"Reza","year":"2022","journal-title":"Am Heart J Plus"},{"issue":"3","key":"hrv230001r18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008685","article-title":"Factors associated with racial and ethnic diversity among heart failure trial participants: a systematic bibliometric review.","volume":"15","author":"Wei","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"1","key":"hrv230001r19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ejhf.v23.1","article-title":"Trial characteristics associated with under-enrolment of females in randomized controlled trials of heart failure with reduced ejection fraction: a systematic review.","volume":"23","author":"Whitelaw","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"hrv230001r20","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMp2209043","article-title":"New federal incentives for diversity in clinical trials.","volume":"387","author":"Hwang","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"hrv230001r21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/1740774510396742","article-title":"Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.","volume":"8","author":"Duda","year":"2011","journal-title":"Clin Trials"},{"issue":"14","key":"hrv230001r22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1717250","article-title":"A cluster-randomized trial of blood-pressure reduction in Black barbershops.","volume":"378","author":"Victor","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"hrv230001r23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1377\/hlthaff.2019.00481","article-title":"The effect of Veterans Health Administration coverage on cost-related medication nonadherence.","volume":"39","author":"Gaffney","year":"2020","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"hrv230001r24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jesp.2009.11.004","article-title":"Aversive racism and medical interactions with Black patients: a field study.","volume":"46","author":"Penner","year":"2010","journal-title":"J Exp Soc Psychol"},{"issue":"12","key":"hrv230001r25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/00001888-200412000-00004","article-title":"Health disparities based on socioeconomic inequities: implications for urban health care.","volume":"79","author":"Fiscella","year":"2004","journal-title":"Acad Med"},{"issue":"6","key":"hrv230001r26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0277-9536(99)00338-X","article-title":"The effect of patient race and socio-economic status on physicians\u2019 perceptions of patients.","volume":"50","author":"van Ryn","year":"2000","journal-title":"Soc Sci Med"},{"issue":"12","key":"hrv230001r27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001918","article-title":"Diversity in clinical and biomedical research: a promise yet to be fulfilled.","volume":"12","author":"Oh","year":"2015","journal-title":"PLoS Med"},{"issue":"7","key":"hrv230001r28","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1089\/jwh.2012.3733","article-title":"Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials.","volume":"21","author":"Coakley","year":"2012","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"hrv230001r29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamacardio.2022.4457","article-title":"Characteristics of clinical trial sites for novel transcatheter mitral and tricuspid valvular therapies.","volume":"8","author":"Nathan","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"1","key":"hrv230001r30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamacardio.2022.4385","article-title":"Inequities in access to structural heart disease interventions.","volume":"8","author":"Reddy","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"2","key":"hrv230001r31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.","volume":"112","author":"Ford","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"hrv230001r32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1037\/hea0000242","article-title":"Understanding associations among race, socioeconomic status, and health: patterns and prospects.","volume":"35","author":"Williams","year":"2016","journal-title":"Health Psychol"},{"key":"hrv230001r33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05339.x","article-title":"Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities.","volume":"1186","author":"Williams","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"hrv230001r34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.socscimed.2004.04.026","article-title":"Are racial disparities in health conditional on socioeconomic status?","volume":"60","author":"Farmer","year":"2005","journal-title":"Soc Sci Med"},{"issue":"20","key":"hrv230001r35","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.117.029652","article-title":"Socioeconomic status and cardiovascular outcomes: challenges and interventions.","volume":"137","author":"Schultz","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"hrv230001r36","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/jamacardio.2020.1458","article-title":"Association of low socioeconomic status with premature coronary heart disease in US adults.","volume":"5","author":"Hamad","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"19","key":"hrv230001r37","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.jacc.2021.09.011","article-title":"Socioeconomic determinants of health and cardiovascular outcomes in women: JACC Review Topic of the Week.","volume":"78","author":"Lindley","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hrv230001r38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.amjcard.2018.10.011","article-title":"Neighborhood socioeconomic status and adverse outcomes in patients with cardiovascular disease.","volume":"123","author":"Topel","year":"2019","journal-title":"Am J Cardiol"},{"key":"hrv230001r39","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-023-00469-4","article-title":"FDA to require diversity plan for clinical trials.","author":"Kozlov","year":"2023","journal-title":"Nature"},{"key":"hrv230001r3","unstructured":"US Food and Drug Administration. Collection of race and ethnicity data in clinical trials: guidance for industry and Food and Drug Administration staff. Published October 2016. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/collection-race-and-ethnicity-data-clinical-trials"},{"key":"hrv230001r8","unstructured":"Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2019 (GBD 2019) cause list mapped to ICD codes. Published 2020."}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2807385\/jamacardiology_reddy_2023_rv_230001_1694030073.22383.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:08:39Z","timestamp":1694617719000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2807385"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2023.2098","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}